Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1874 2
1876 1
1877 1
1901 1
1906 3
1908 1
1910 1
1947 1
1953 1
1954 3
1956 3
1957 3
1958 1
1959 1
1960 2
1968 1
1971 3
1972 1
1973 1
1974 4
1975 8
1976 5
1977 7
1978 6
1979 11
1980 13
1981 13
1982 4
1983 3
1984 9
1985 12
1986 12
1987 24
1988 11
1989 19
1990 14
1991 12
1992 14
1993 16
1994 7
1995 21
1996 22
1997 20
1998 12
1999 15
2000 26
2001 24
2002 23
2003 15
2004 16
2005 17
2006 22
2007 25
2008 23
2009 31
2010 21
2011 40
2012 25
2013 20
2014 31
2015 21
2016 35
2017 32
2018 53
2019 46
2020 49
2021 71
2022 59
2023 53
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

1,084 results

Results by year

Filters applied: . Clear all
Page 1
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK, Bhatia S, Budde LE, Chokshi S, Davies M, Elshoury A, Gesthalter Y, Hegde A, Jain M, Kaffenberger BH, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Patil P, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Lyons M, Dwyer M, Hang L. Thompson JA, et al. J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020. J Natl Compr Canc Netw. 2022. PMID: 35390769 Review.
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Ghosh M, Jaiyesimi I, Mammen JS, Naing A, Nastoupil LJ, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor M, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Funchain P, Bollin K. Schneider BJ, et al. Among authors: thompson ja. J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1. J Clin Oncol. 2021. PMID: 34724392
Melanoma.
Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daud A, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM; National Comprehensive Cancer Network. Coit DG, et al. Among authors: thompson ja. J Natl Compr Canc Netw. 2012 Mar;10(3):366-400. doi: 10.6004/jnccn.2012.0036. J Natl Compr Canc Netw. 2012. PMID: 22393197 No abstract available.
Point-of-care oral-based diagnostics.
Hart RW, Mauk MG, Liu C, Qiu X, Thompson JA, Chen D, Malamud D, Abrams WR, Bau HH. Hart RW, et al. Among authors: thompson ja. Oral Dis. 2011 Nov;17(8):745-52. doi: 10.1111/j.1601-0825.2011.01808.x. Epub 2011 Apr 26. Oral Dis. 2011. PMID: 21521419 Free PMC article. Review.
Melanoma.
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK; NCCN Melanoma Panel. Coit DG, et al. Among authors: thompson ja. J Natl Compr Canc Netw. 2009 Mar;7(3):250-75. doi: 10.6004/jnccn.2009.0020. J Natl Compr Canc Netw. 2009. PMID: 19401060 No abstract available.
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee JB, Ho Lee L, O'Keeffe JA, Lewis N, Pavlakis GN, Thompson JA. Leidner R, et al. Among authors: thompson ja. J Immunother Cancer. 2023 Oct;11(10):e007725. doi: 10.1136/jitc-2023-007725. J Immunother Cancer. 2023. PMID: 37907221 Free PMC article. Clinical Trial.
Driving with retinitis pigmentosa.
Heath Jeffery RC, Lo J, Thompson JA, Lamey TM, McLaren TL, DeRoach JN, Kabilio MS, Chen FK. Heath Jeffery RC, et al. Among authors: thompson ja. Ophthalmic Genet. 2023 Aug;44(4):352-360. doi: 10.1080/13816810.2023.2196338. Epub 2023 Apr 4. Ophthalmic Genet. 2023. PMID: 37013444
Perspectives on transcultural care.
Bjarnason D, Mick J, Thompson JA, Cloyd E. Bjarnason D, et al. Among authors: thompson ja. Nurs Clin North Am. 2009 Dec;44(4):495-503. doi: 10.1016/j.cnur.2009.07.009. Nurs Clin North Am. 2009. PMID: 19850185 Review.
1,084 results